Literature DB >> 8768534

[Dyslipemia in type-2 diabetes. A risk factor for macroangiopathy?].

N Lara Suriñach1, J Franch Nadal, J Morató Griera, A Egido Polo, J Puig Galy, J Castillejo Medina.   

Abstract

OBJECTIVE: To study the association of dyslipemia with macroangiopathy in patients with type II diabetes mellitus.
DESIGN: Descriptive crossover study.
SETTING: An urban health district with a socially and economically depressed elderly population. PATIENTS: A randomised sample among the diabetics registered in the health district (n = 449).
MEASUREMENTS AND MAIN RESULTS: Different factors in the lipidic profile were studied, as was the presence of diabetic macroangiopathy and some of the associated risk factors. The following were considered cut-off figures with a predictive value of cardiovascular risk: overall cholesterol >or= 240 mg/dl (40% of the sample), HDL < 35 mg/dl (27%), LDL >or= 160 mg/dl (43%), triglycerides >or= 200 mg/dl (25%), atherogenic index >or= 4.5 (73%) and HDL/LDL balance >or= 0.2 (83%). 85.5% of the diabetics in the sample presented one of the lipidic disorders mentioned above. In the multivariant analysis only hypertriglyceridaemia was associated with a higher prevalence of peripheral vasculopathy.
CONCLUSIONS: A high percentage of patients with type II DM presented disorders in their lipidic profile. But, unlike the norm in the general population, only hypertriglyceridaemia displayed a statistically significant association with diabetic macroangiopathy. The role of the other dyslipemic factors was limited.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8768534

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  1 in total

1.  Incidence, prevalence and coronary heart disease risk level in known Type 2 diabetes: a sentinel practice network study in the Basque Country, Spain.

Authors:  J M Arteagoitia; M I Larrañaga; J L Rodriguez; I Fernandez; J A Piniés
Journal:  Diabetologia       Date:  2003-06-27       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.